









Markets
/
Stocks
/
nasdaq-clov
/

Clover Health Investments Corp

CLOV

2.130USD

+0.090+4.41%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

1.08BMarket Cap

LossP/E TTM



Clover Health Investments Corp

2.130

+0.090+4.41%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Clover Health Investments Corp

Currency: USD Updated: 2026-02-06

Key Insights

Clover Health Investments Corp's fundamentals are relatively very healthy, with industry-average ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 51 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 2.86.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Clover Health Investments Corp's Score

Industry at a Glance

Industry Ranking

51 / 75

Overall Ranking

234 / 4521

Industry

Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Clover Health Investments Corp Highlights

StrengthsRisks

Clover Health Investments, Corp. is a physician enablement technology company. The Company is focused on bringing access to healthcare to everyone on Medicare. This includes a health equity-based focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. For healthcare providers outside its MA plan, it focuses on extending the benefits of its data-driven technology platform to a wider audience via its subsidiary, Counterpart Health, Inc.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 25.04% year-on-year.

Fairly Valued

The company’s latest PE is -18.37, at a medium 3-year percentile range.

Institutional Buying

The latest institutional holdings are 137.18M shares, increasing 0.12% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 23.39M shares of this stock.

Analyst Rating

Based on 4 analysts

Hold

Current Rating

2.862

Target Price

+40.32%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Clover Health Investments Corp is 7.97, ranking 38 out of 75 in the Healthcare Providers & Services industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 496.65M, representing a year-over-year increase of 50.05%, while its net profit experienced a year-over-year increase of 166.27%.

Score

Industry at a Glance

Previous score

7.97

Change



Financials

9.18

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

6.24

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

8.34

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

8.72

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.37

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Clover Health Investments Corp's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Clover Health Investments Corp is 8.15, ranking 16 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is -18.37, which is -94.38% below the recent high of -1.03 and -303.07% above the recent low of -74.04.

Score

Industry at a Glance

Previous score

8.15

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 51/75

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Clover Health Investments Corp is 6.50, ranking 53 out of 75 in the Healthcare Providers & Services industry. The average price target is 3.00, with a high of 3.70 and a low of 3.00.

Score

Industry at a Glance

Previous score

6.50

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 4 analysts

Hold

Current Rating

2.862

Target Price

+40.32%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Clover Health Investments Corp

CLOV

Unitedhealth Group Inc

UNH

Humana Inc

HUM

Cigna Group

Elevance Health Inc

ELV

Centene Corp

CNC

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Clover Health Investments Corp is 6.78, ranking 40 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 2.66 and the support level at 1.81, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.58

Change

0.2

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.084

Sell

RSI(14)

35.740

Neutral

STOCH(KDJ)(9,3,3)

14.930

Neutral

ATR(14)

0.117

Low Volatility

CCI(14)

-89.602

Neutral

Williams %R

85.714

Oversold

TRIX(12,20)

-0.651

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

2.126

Buy

MA10

2.230

Sell

MA20

2.426

Sell

MA50

2.500

Sell

MA100

2.704

Sell

MA200

2.848

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Clover Health Investments Corp is 3.00, ranking 60 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 36.85%, representing a quarter-over-quarter decrease of 0.70%. The largest institutional shareholder is The Vanguard, holding a total of 23.39M shares, representing 5.51% of shares outstanding, with 12.10% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

26.79M

-0.05%

The Vanguard Group, Inc.

Star Investors

22.96M

-4.91%

Geode Capital Management, L.L.C.

9.72M

-1.25%

State Street Investment Management (US)

8.95M

+19.24%

Renaissance Technologies LLC

Star Investors

7.71M

-26.50%

PNC Investments LLC

4.46M

Charles Schwab Investment Management, Inc.

4.27M

+9.70%

Northern Trust Investments, Inc.

3.07M

-2.53%

Divisadero Street Capital Management, LP

2.77M

Susquehanna International Group, LLP

2.70M

-9.69%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Clover Health Investments Corp is 4.09, ranking 52 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 2.16. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. Clover Health Investments Corp’s latest ESG disclosure is at an average level in the Healthcare Providers & Services industry, showing no material impact on overall risk.